E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer

NCT04015336 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

NIH

Sponsor class

Stopped Logistical challenges

Conditions

Papillomavirus Infections
Oropharyngeal Neoplasms

Interventions

BIOLOGICAL: E7 T-Cell Receptor (TCR)

Sponsor

National Cancer Institute (NCI)